Free Cash Flow

Orphazyme A/S (ORPH)

$ 4.51
-0.06 -1.31%

Free Cash Flow

Year
A/P
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue ----------
Revenue (%)
Operating Cash Flow ----------
Operating Cash Flow (%)
Capital Expenditure ----------
Capital Expenditure (%)
Free Cash Flow ----------

FCF Unlevered from cash flow statement